Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus

Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-α are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood...

Full description

Saved in:
Bibliographic Details
Published inClinical and experimental immunology Vol. 152; no. 3; pp. 482 - 487
Main Authors Komatsuda, A, Wakui, H, Iwamoto, K, Ozawa, M, Togashi, M, Masai, R, Maki, N, Hatakeyama, T, Sawada, K
Format Journal Article
LanguageEnglish
Published Oxford, UK Oxford, UK : Blackwell Publishing Ltd 01.06.2008
Blackwell Publishing Ltd
Blackwell
Blackwell Science Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-α are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription-polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN-α and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN-α and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-α mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-α mRNA in PBMCs may also contribute to the pathogenesis of human lupus.
AbstractList Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-alpha are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription-polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN-alpha and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN-alpha and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-alpha mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-alpha mRNA in PBMCs may also contribute to the pathogenesis of human lupus.Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-alpha are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription-polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN-alpha and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN-alpha and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-alpha mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-alpha mRNA in PBMCs may also contribute to the pathogenesis of human lupus.
Summary Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll‐like receptors (TLR‐7 and TLR‐9) and interferon (IFN)‐α are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR‐9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real‐time reverse transcription–polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN‐α and LY6E (a type I IFN‐inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN‐α and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN‐α mRNA in SLE patients. These results suggest that up‐regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN‐α mRNA in PBMCs may also contribute to the pathogenesis of human lupus.
Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-α are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription–polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN-α and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN-α and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-α mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-α mRNA in PBMCs may also contribute to the pathogenesis of human lupus.
Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-alpha are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription-polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN-alpha and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN-alpha and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-alpha mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-alpha mRNA in PBMCs may also contribute to the pathogenesis of human lupus.
Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-α are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription–polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2 , TLR3 , TLR4 , TLR5 , TLR7 , TLR8 , TLR9 , IFN-α and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2 , TLR7 , TLR9, IFN-α and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN-α mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN-α mRNA in PBMCs may also contribute to the pathogenesis of human lupus.
SummaryRecent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)- alpha are involved in the pathogenesis of murine lupus. Recent studies using flow cytometry have also shown increased expression of TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients. In this study, we performed quantitative real-time reverse transcription-polymerase chain reaction analyses of PBMCs from 21 SLE patients and 21 healthy subjects, to estimate TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, IFN- alpha and LY6E (a type I IFN-inducible gene) mRNA expression levels. Expression levels of TLR2, TLR7, TLR9, IFN- alpha and LY6E mRNAs in SLE patients were significantly higher than those in healthy controls. Expression levels of TLR7 and TLR9 mRNAs correlated with that of IFN- alpha mRNA in SLE patients. These results suggest that up-regulated expression of TLR7 and TLR9 mRNAs together with increased expression of IFN- alpha mRNA in PBMCs may also contribute to the pathogenesis of human lupus.
Author Komatsuda, A
Hatakeyama, T
Maki, N
Wakui, H
Togashi, M
Sawada, K
Masai, R
Ozawa, M
Iwamoto, K
Author_xml – sequence: 1
  fullname: Komatsuda, A
– sequence: 2
  fullname: Wakui, H
– sequence: 3
  fullname: Iwamoto, K
– sequence: 4
  fullname: Ozawa, M
– sequence: 5
  fullname: Togashi, M
– sequence: 6
  fullname: Masai, R
– sequence: 7
  fullname: Maki, N
– sequence: 8
  fullname: Hatakeyama, T
– sequence: 9
  fullname: Sawada, K
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20349283$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18373699$$D View this record in MEDLINE/PubMed
BookMark eNqNksGO0zAQhi20iO0WXgF8gVuCYydOfABpVS2w0gok2J4tx520Lk4c7IRtX4GnxqGlC6ddX2xr_vk84_kv0FnnOkAIZyTN4nq7TTPGi4TSXKSUkColjOc83T1Bs1PgDM0IISIRGcnP0UUI23jlnNNn6DyrWMm4EDP0a9knHtajVQOsMOx6DyEY12HX4FtnbWLNd8AeNPSD8wG3Xz9fBmw63IM3_Qa8sri2zq1w62KRo7agPNZgbcCNdy3u1WCgGwK-M8MGh30YoDUa27EfAwa_HzbQqsGFMTxHTxtlA7w47nO0_HB1u_iU3Hz5eL24vEl0UVU8KZsyh6rINNGKVlDUIGiuV3VJoSYFVYVghaIrxWrIG1aTjImsoXVVMKVJmRVsjt4fuP1Yt7DSsbrYhey9aZXfS6eM_D_SmY1cu5-S5gWjkTdHb44A736MEAbZmjC1rDpwY5BcZILwkjwozEtelJw_TKQkZ6LMWBS-_Lf2U9F_BxoFr48CFbSyjVedNuGko4TlglYTqDrotHcheGjuUUROHpNbOVlJTlaSk8fkH4_J3f3_nVK1GeKU3fRbxj4G8O4AuDMW9o9-WC6urqdTzH91yG-Uk2rtY3_Lb9NgolgwQjn7DUvR95E
CODEN CEXIAL
CitedBy_id crossref_primary_10_1016_j_clim_2011_04_016
crossref_primary_10_1371_journal_pone_0107257
crossref_primary_10_3109_09546634_2012_697110
crossref_primary_10_1136_rmdopen_2022_002864
crossref_primary_10_1016_j_bbi_2021_09_009
crossref_primary_10_1155_2012_715190
crossref_primary_10_1155_2016_7697592
crossref_primary_10_1093_infdis_jit262
crossref_primary_10_1038_icb_2011_111
crossref_primary_10_3389_fimmu_2019_01601
crossref_primary_10_3390_jcm9020541
crossref_primary_10_1002_eji_201646641
crossref_primary_10_1073_pnas_1209372109
crossref_primary_10_1172_JCI42213
crossref_primary_10_3390_cells13231946
crossref_primary_10_1101_gr_265249_120
crossref_primary_10_1093_rheumatology_keq001
crossref_primary_10_4049_jimmunol_1202195
crossref_primary_10_33549_physiolres_934167
crossref_primary_10_3109_14397595_2015_1030102
crossref_primary_10_3389_fimmu_2015_00550
crossref_primary_10_1016_j_humimm_2013_08_006
crossref_primary_10_1155_2010_498980
crossref_primary_10_1177_0961203311425522
crossref_primary_10_1007_s11033_010_0590_4
crossref_primary_10_1016_j_humimm_2024_111104
crossref_primary_10_1111_imj_12039
crossref_primary_10_1186_s13075_022_02766_1
crossref_primary_10_1186_s13293_024_00650_y
crossref_primary_10_1016_j_clim_2013_10_007
crossref_primary_10_1111_nyas_13534
crossref_primary_10_1371_journal_pgen_1003336
crossref_primary_10_1620_tjem_240_199
crossref_primary_10_1016_j_clim_2016_07_015
crossref_primary_10_1007_s10875_013_9887_0
crossref_primary_10_3389_fphys_2017_00508
crossref_primary_10_1016_j_jid_2016_09_008
crossref_primary_10_1186_ar4193
crossref_primary_10_1007_s00281_014_0445_5
crossref_primary_10_3389_fimmu_2017_01075
crossref_primary_10_3892_etm_2019_7290
crossref_primary_10_1007_s00251_016_0961_7
crossref_primary_10_1172_jci_insight_169584
crossref_primary_10_1177_0961203313511553
crossref_primary_10_1111_j_1365_4632_2009_04111_x
crossref_primary_10_1016_j_rdc_2009_03_003
crossref_primary_10_1186_ar3803
crossref_primary_10_1186_s13075_015_0886_9
crossref_primary_10_1507_endocrj_K09E_291
crossref_primary_10_1080_14728222_2020_1832464
crossref_primary_10_1136_rmdopen_2022_002876
crossref_primary_10_1007_s12016_010_8208_0
crossref_primary_10_1038_aps_2015_91
crossref_primary_10_1002_jcb_26155
crossref_primary_10_1016_j_biopha_2017_09_079
crossref_primary_10_3390_v4123701
crossref_primary_10_3892_mmr_2015_3730
crossref_primary_10_1136_ard_2009_124313
crossref_primary_10_1186_s10020_023_00717_3
crossref_primary_10_18705_2782_3806_2022_2_2_63_71
crossref_primary_10_1111_sji_12520
crossref_primary_10_1016_j_clim_2014_01_006
crossref_primary_10_4078_jrd_2018_25_2_81
crossref_primary_10_1016_j_jns_2009_12_018
crossref_primary_10_1007_s11033_014_3447_4
crossref_primary_10_1093_intimm_dxy032
crossref_primary_10_3389_fimmu_2019_01243
crossref_primary_10_1007_s12026_012_8270_1
crossref_primary_10_1080_08820139_2018_1515223
crossref_primary_10_1038_s41584_019_0307_6
crossref_primary_10_1002_art_39867
crossref_primary_10_1371_journal_pone_0260565
crossref_primary_10_2217_epi_2019_0145
crossref_primary_10_1093_rheumatology_ket316
crossref_primary_10_3892_etm_2021_10682
crossref_primary_10_1016_j_micpath_2023_106300
crossref_primary_10_3389_fimmu_2016_00022
crossref_primary_10_1172_JCI120288
crossref_primary_10_3390_ijms22136920
crossref_primary_10_1177_0300985810370005
crossref_primary_10_1111_j_1365_2249_2009_04036_x
crossref_primary_10_1371_journal_pone_0120383
crossref_primary_10_1007_s12016_013_8402_y
crossref_primary_10_1111_j_1365_2249_2010_04176_x
crossref_primary_10_1093_rheumatology_ker400
crossref_primary_10_1186_ar2584
crossref_primary_10_1186_ar3277
crossref_primary_10_3390_ijms20194732
crossref_primary_10_1007_s10067_012_2033_1
crossref_primary_10_1517_14712598_2010_534080
crossref_primary_10_3390_ijms20133234
crossref_primary_10_1016_j_cellimm_2014_12_002
crossref_primary_10_1155_2014_381418
crossref_primary_10_4049_jimmunol_0804318
crossref_primary_10_1016_j_heliyon_2024_e32752
crossref_primary_10_1111_j_1365_3083_2010_02450_x
crossref_primary_10_1007_s00393_015_0022_x
crossref_primary_10_1111_j_2041_1014_2009_00551_x
crossref_primary_10_3389_fimmu_2019_01546
crossref_primary_10_1080_15569543_2018_1469512
crossref_primary_10_1111_ahg_12458
crossref_primary_10_1089_jir_2012_0014
crossref_primary_10_3389_fphar_2014_00265
crossref_primary_10_1186_s40364_022_00436_7
crossref_primary_10_3945_jn_110_135517
crossref_primary_10_4049_jimmunol_1102977
crossref_primary_10_1371_journal_ppat_1005053
crossref_primary_10_1007_s00296_014_3012_4
crossref_primary_10_1016_j_ejmech_2020_112238
crossref_primary_10_1016_j_xcrm_2023_101036
crossref_primary_10_1242_dmm_016451
crossref_primary_10_1002_eji_201445219
crossref_primary_10_1111_cei_13566
crossref_primary_10_2174_1389201023666220114162347
crossref_primary_10_1155_2019_1703842
crossref_primary_10_1186_s12974_021_02215_x
crossref_primary_10_1038_s41423_019_0254_9
crossref_primary_10_1042_BJ20090013
crossref_primary_10_1371_journal_pone_0198325
crossref_primary_10_1016_j_immuni_2020_04_004
crossref_primary_10_1007_s10238_011_0161_6
crossref_primary_10_1016_j_bbrc_2010_09_132
crossref_primary_10_1371_journal_pone_0023855
crossref_primary_10_1111_cei_13041
crossref_primary_10_1038_srep03792
crossref_primary_10_1186_s12929_018_0436_2
Cites_doi 10.1084/jem.20050338
10.1002/art.22044
10.1038/nri1957
10.1016/j.smim.2006.12.005
10.1111/j.1365-2796.1990.tb00144.x
10.1084/jem.20050914
10.1136/jcp.56.7.481
10.1016/S0140-6736(07)60279-7
10.4049/jimmunol.177.2.1349
10.1016/j.immuni.2006.07.014
10.1002/art.21553
10.1084/jem.20021553
10.1146/annurev.immunol.21.120601.141152
10.1073/pnas.0337679100
10.1016/j.immuni.2006.07.013
10.1016/j.cell.2006.02.015
10.1016/j.autrev.2006.05.002
10.1002/art.1780400928
10.1038/nri1456
10.1126/science.1105160
10.1080/08916930310001605873
10.1002/art.1780251101
10.1073/pnas.0603912103
10.1002/art.1780350606
10.1002/art.22197
10.1016/j.coi.2006.09.014
ContentType Journal Article
Copyright 2008 British Society for Immunology
2008 INIST-CNRS
2008 British Society for Immunology 2008
Copyright_xml – notice: 2008 British Society for Immunology
– notice: 2008 INIST-CNRS
– notice: 2008 British Society for Immunology 2008
DBID FBQ
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7S9
L.6
7X8
5PM
DOI 10.1111/j.1365-2249.2008.03646.x
DatabaseName AGRIS
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
Immunology Abstracts
AGRICOLA
AGRICOLA - Academic
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
AGRICOLA
MEDLINE


AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1365-2249
EndPage 487
ExternalDocumentID PMC2453201
18373699
20349283
10_1111_j_1365_2249_2008_03646_x
CEI3646
US201300893026
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
169
29B
2WC
31~
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
5WD
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
A8Z
AABZA
AACZT
AAESR
AAEVG
AAHHS
AAONW
AAPXW
AARHZ
AAUAY
AAVAP
AAZKR
ABCQN
ABCUV
ABDBF
ABDFA
ABEJV
ABEML
ABGNP
ABJNI
ABLJU
ABNHQ
ABOCM
ABPTD
ABPVW
ABQNK
ABVGC
ABXVV
ACAHQ
ACCFJ
ACFBH
ACGFO
ACGFS
ACMXC
ACPOU
ACPRK
ACSCC
ACUFI
ACUHS
ACVCV
ACXQS
ADBBV
ADEOM
ADIPN
ADIYS
ADIZJ
ADKYN
ADMGS
ADOZA
ADQBN
ADVEK
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIMD
AEMQT
AENEX
AEQDE
AFBPY
AFEBI
AFFQV
AFFZL
AFGKR
AFRAH
AFTUV
AFXAL
AFZJQ
AGMDO
AGUTN
AHMMS
AIACR
AIAGR
AIURR
AIWBW
AJAOE
AJBDE
AJDVS
AJEEA
AJNCP
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALXQX
AMBMR
AMYDB
AOIJS
ATGXG
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BCRHZ
BEYMZ
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EAS
EBB
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FBQ
FUBAC
G-S
G.N
GODZA
GX1
H.X
H13
HF~
HZI
HZ~
IH2
IHE
IX1
J0M
J5H
K48
KBUDW
KBYEO
KOP
KSI
KSN
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NOMLY
NU-
O66
O9-
OAUYM
OBS
OCZFY
OHT
OIG
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
Q~Q
R.K
ROL
ROX
RPM
RX1
SUPJJ
SV3
TEORI
TR2
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WQJ
WVDHM
WXI
X7M
XG1
Y6R
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAFWJ
AAMMB
AEFGJ
AGORE
AGXDD
AHGBF
AIDQK
AIDYY
AJBYB
WIN
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
H94
7S9
L.6
7X8
5PM
ID FETCH-LOGICAL-c5886-7f74e851c0ca28e5be924cdb72eb052a5935a2da3be4f3b01391f2b853ac07153
IEDL.DBID DR2
ISSN 0009-9104
1365-2249
IngestDate Thu Aug 21 13:58:46 EDT 2025
Fri Jul 11 05:05:15 EDT 2025
Fri Jul 11 07:57:57 EDT 2025
Fri Jul 11 08:23:20 EDT 2025
Thu Apr 03 06:57:58 EDT 2025
Mon Jul 21 09:15:52 EDT 2025
Tue Jul 01 03:52:22 EDT 2025
Thu Apr 24 23:11:03 EDT 2025
Wed Aug 20 07:27:49 EDT 2025
Thu Apr 03 09:44:55 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Human
peripheral blood mononuclear cells
Immunopathology
Connective tissue disease
Skin disease
interferon-α
Alpha interferon
real-time reverse transcription-polymerase chain reaction
Autoimmune disease
Toll like receptor
Biochemistry
Biophysics
Blood cell
Regulation(control)
Systemic lupus erythematosus
Mononuclear cell
Messenger RNA
Systemic disease
Toll- like receptors
Molecular biology
Reverse transcription polymerase chain reaction
Real time polymerase chain reaction
Language English
License https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5886-7f74e851c0ca28e5be924cdb72eb052a5935a2da3be4f3b01391f2b853ac07153
Notes http://dx.doi.org/10.1111/j.1365-2249.2008.03646.x
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://doi.org/10.1111/j.1365-2249.2008.03646.x
PMID 18373699
PQID 20439713
PQPubID 23462
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2453201
proquest_miscellaneous_69190670
proquest_miscellaneous_47657661
proquest_miscellaneous_20439713
pubmed_primary_18373699
pascalfrancis_primary_20349283
crossref_primary_10_1111_j_1365_2249_2008_03646_x
crossref_citationtrail_10_1111_j_1365_2249_2008_03646_x
wiley_primary_10_1111_j_1365_2249_2008_03646_x_CEI3646
fao_agris_US201300893026
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2008
PublicationDateYYYYMMDD 2008-06-01
PublicationDate_xml – month: 06
  year: 2008
  text: June 2008
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: England
PublicationTitle Clinical and experimental immunology
PublicationTitleAlternate Clin Exp Immunol
PublicationYear 2008
Publisher Oxford, UK : Blackwell Publishing Ltd
Blackwell Publishing Ltd
Blackwell
Blackwell Science Inc
Publisher_xml – name: Oxford, UK : Blackwell Publishing Ltd
– name: Blackwell Publishing Ltd
– name: Blackwell
– name: Blackwell Science Inc
References 2007; 19
1982; 25
1997; 40
1990; 227
2007; 369
2000; 27
2006; 54
2005; 202
2006; 25
2004; 4
2003; 36
2005; 307
2006; 5
2006; 18
2006; 6
1992; 35
2007; 34
2003; 100
2003; 21
2006; 177
2006; 103
2003; 197
2003; 56
2006; 124
Pascual (2022010405183746300_b7) 2006; 18
Subramanian (2022010405183746300_b23) 2006; 103
Mackay (2022010405183746300_b3) 2003; 21
Papadimitraki (2022010405183746300_b11) 2006; 54
Baechler (2022010405183746300_b26) 2003; 100
Barrat (2022010405183746300_b28) 2005; 202
D'Cruz (2022010405183746300_b2) 2007; 369
Hochberg (2022010405183746300_b15) 1997; 40
Wu (2022010405183746300_b19) 2006; 54
Feng (2022010405183746300_b13) 2006; 54
Christensen (2022010405183746300_b9) 2007; 19
Lartigue (2022010405183746300_b20) 2006; 177
Cook (2022010405183746300_b17) 2000; 27
Mok (2022010405183746300_b1) 2003; 56
Akira (2022010405183746300_b10) 2006; 124
Tan (2022010405183746300_b14) 1982; 25
Migita (2022010405183746300_b12) 2007; 34
Bennett (2022010405183746300_b27) 2003; 197
McGaha (2022010405183746300_b5) 2005; 307
Christensen (2022010405183746300_b18) 2005; 202
Christensen (2022010405183746300_b22) 2006; 25
Carroll (2022010405183746300_b4) 2004; 4
Bombardier (2022010405183746300_b16) 1992; 35
Koutouzov (2022010405183746300_b6) 2006; 5
Marshak-Rothstein (2022010405183746300_b8) 2006; 6
Berland (2022010405183746300_b21) 2006; 25
Gota (2022010405183746300_b25) 2003; 36
Rönnblom (2022010405183746300_b24) 1990; 227
17307106 - Lancet. 2007 Feb 17;369(9561):587-96
17276080 - Semin Immunol. 2007 Feb;19(1):11-23
16497588 - Cell. 2006 Feb 24;124(4):783-801
9324032 - Arthritis Rheum. 1997 Sep;40(9):1725
16027240 - J Exp Med. 2005 Jul 18;202(2):321-31
15681388 - Science. 2005 Jan 28;307(5709):590-3
12642603 - J Exp Med. 2003 Mar 17;197(6):711-23
17027892 - Autoimmun Rev. 2006 Oct;5(8):554-62
16385525 - Arthritis Rheum. 2006 Jan;54(1):336-42
16947629 - Arthritis Rheum. 2006 Sep;54(9):2951-62
16973389 - Immunity. 2006 Sep;25(3):417-28
17075805 - Arthritis Rheum. 2006 Nov;54(11):3601-11
16973388 - Immunity. 2006 Sep;25(3):429-40
17011763 - Curr Opin Immunol. 2006 Dec;18(6):676-82
16230478 - J Exp Med. 2005 Oct 17;202(8):1131-9
14984028 - Autoimmunity. 2003 Dec;36(8):511-8
12604793 - Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2610-5
1599520 - Arthritis Rheum. 1992 Jun;35(6):630-40
17295441 - J Rheumatol. 2007 Mar;34(3):493-500
12835292 - J Clin Pathol. 2003 Jul;56(7):481-90
15459673 - Nat Rev Immunol. 2004 Oct;4(10):825-31
17063184 - Nat Rev Immunol. 2006 Nov;6(11):823-35
16777955 - Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9970-5
10955329 - J Rheumatol. 2000 Aug;27(8):1892-5
12427767 - Annu Rev Immunol. 2003;21:231-64
16818796 - J Immunol. 2006 Jul 15;177(2):1349-54
1690258 - J Intern Med. 1990 Mar;227(3):207-10
7138600 - Arthritis Rheum. 1982 Nov;25(11):1271-7
References_xml – volume: 25
  start-page: 1271
  year: 1982
  end-page: 7
  article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus
  publication-title: Arthritis Rheum
– volume: 25
  start-page: 417
  year: 2006
  end-page: 28
  article-title: Toll‐like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus
  publication-title: Immunity
– volume: 4
  start-page: 825
  year: 2004
  end-page: 31
  article-title: A protective role for innate immunity in systemic lupus erythematosus
  publication-title: Nat Rev Immunol
– volume: 307
  start-page: 590
  year: 2005
  end-page: 3
  article-title: Restoration of tolerance in lupus by targeted inhibitory receptor expression
  publication-title: Science
– volume: 369
  start-page: 587
  year: 2007
  end-page: 96
  article-title: Systemic lupus erythematosus
  publication-title: Lancet
– volume: 103
  start-page: 9970
  year: 2006
  end-page: 5
  article-title: A translocation accelerates systemic autoimmunity in murine lupus
  publication-title: Proc Natl Acad Sci USA
– volume: 54
  start-page: 2951
  year: 2006
  end-page: 62
  article-title: Association of increased interferon‐inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus
  publication-title: Arthritis Rheum
– volume: 202
  start-page: 321
  year: 2005
  end-page: 31
  article-title: Toll‐like receptor 9 controls anti‐DNA autoantibody production in murine lupus
  publication-title: J Exp Med
– volume: 40
  start-page: 1725
  year: 1997
  article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
  publication-title: Arthritis Rheum
– volume: 100
  start-page: 2610
  year: 2003
  end-page: 15
  article-title: Interferon‐inducible gene expression signature in peripheral blood cells of patients with severe lupus
  publication-title: Proc Natl Acad Sci USA
– volume: 25
  start-page: 429
  year: 2006
  end-page: 40
  article-title: Toll‐like receptor 7‐dependent loss of B cell tolerance in pathogenic autoantibody knockin mice
  publication-title: Immunity
– volume: 36
  start-page: 511
  year: 2003
  end-page: 18
  article-title: Induction of clinical autoimmune disease by therapeutic interferon‐alpha
  publication-title: Autoimmunity
– volume: 21
  start-page: 231
  year: 2003
  end-page: 64
  article-title: BAFF and APRIL: a tutorial on B cell survival
  publication-title: Annu Rev Immunol
– volume: 124
  start-page: 783
  year: 2006
  end-page: 801
  article-title: Pathogen reaction and innate immunity
  publication-title: Cell
– volume: 27
  start-page: 1892
  year: 2000
  end-page: 5
  article-title: Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity
  publication-title: J Rheumatol
– volume: 35
  start-page: 630
  year: 1992
  end-page: 40
  article-title: Derivation of the SLEDAI: a disease activity index for lupus patients
  publication-title: Arthritis Rheum
– volume: 6
  start-page: 823
  year: 2006
  end-page: 35
  article-title: Toll‐like receptors in systemic autoimmune disease
  publication-title: Nat Rev Immunol
– volume: 19
  start-page: 11
  year: 2007
  end-page: 23
  article-title: Regulation of lupus‐related autoantibody production and clinical disease by Toll‐like receptors
  publication-title: Semin Immunol
– volume: 54
  start-page: 3601
  year: 2006
  end-page: 11
  article-title: Expansion of toll‐like receptor 9‐expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process
  publication-title: Arthritis Rheum
– volume: 197
  start-page: 711
  year: 2003
  end-page: 23
  article-title: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
  publication-title: J Exp Med
– volume: 34
  start-page: 493
  year: 2007
  end-page: 500
  article-title: Toll‐like receptor expression in lupus peripheral blood mononuclear cells
  publication-title: J Rheumatol
– volume: 5
  start-page: 554
  year: 2006
  end-page: 62
  article-title: Type‐I interferons and systemic lupus erythematosus
  publication-title: Autoimmun Rev
– volume: 227
  start-page: 207
  year: 1990
  end-page: 10
  article-title: Possible induction of systemic lupus erythematosus by interferon‐alpha treatment in a patient with a malignant carcinoid tumour
  publication-title: J Intern Med
– volume: 202
  start-page: 1131
  year: 2005
  end-page: 9
  article-title: Nucleic acids of mammalian origin can act as endogenous ligands for Toll‐like receptors and may promote systemic lupus erythematosus
  publication-title: J Exp Med
– volume: 56
  start-page: 481
  year: 2003
  end-page: 90
  article-title: Pathogenesis of systemic lupus erythematosus
  publication-title: J Clin Pathol
– volume: 18
  start-page: 676
  year: 2006
  end-page: 82
  article-title: Systemic lupus erythematosus: all roads lead to type I interferons
  publication-title: Curr Opin Immunol
– volume: 54
  start-page: 336
  year: 2006
  end-page: 42
  article-title: Toll‐like receptor 9 signaling protects against murine lupus
  publication-title: Arthritis Rheum
– volume: 177
  start-page: 1349
  year: 2006
  end-page: 54
  article-title: Role of TLR9 in anti‐nucleosome and anti‐DNA antibody production in mutation‐induced murine lupus
  publication-title: J Immunol
– volume: 202
  start-page: 321
  year: 2005
  ident: 2022010405183746300_b18
  article-title: Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
  publication-title: J Exp Med
  doi: 10.1084/jem.20050338
– volume: 54
  start-page: 2951
  year: 2006
  ident: 2022010405183746300_b13
  article-title: Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22044
– volume: 6
  start-page: 823
  year: 2006
  ident: 2022010405183746300_b8
  article-title: Toll-like receptors in systemic autoimmune disease
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1957
– volume: 19
  start-page: 11
  year: 2007
  ident: 2022010405183746300_b9
  article-title: Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors
  publication-title: Semin Immunol
  doi: 10.1016/j.smim.2006.12.005
– volume: 27
  start-page: 1892
  year: 2000
  ident: 2022010405183746300_b17
  article-title: Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity
  publication-title: J Rheumatol
– volume: 227
  start-page: 207
  year: 1990
  ident: 2022010405183746300_b24
  article-title: Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.1990.tb00144.x
– volume: 202
  start-page: 1131
  year: 2005
  ident: 2022010405183746300_b28
  article-title: Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus
  publication-title: J Exp Med
  doi: 10.1084/jem.20050914
– volume: 56
  start-page: 481
  year: 2003
  ident: 2022010405183746300_b1
  article-title: Pathogenesis of systemic lupus erythematosus
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.56.7.481
– volume: 369
  start-page: 587
  year: 2007
  ident: 2022010405183746300_b2
  article-title: Systemic lupus erythematosus
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)60279-7
– volume: 177
  start-page: 1349
  year: 2006
  ident: 2022010405183746300_b20
  article-title: Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus
  publication-title: J Immunol
  doi: 10.4049/jimmunol.177.2.1349
– volume: 25
  start-page: 429
  year: 2006
  ident: 2022010405183746300_b21
  article-title: Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice
  publication-title: Immunity
  doi: 10.1016/j.immuni.2006.07.014
– volume: 34
  start-page: 493
  year: 2007
  ident: 2022010405183746300_b12
  article-title: Toll-like receptor expression in lupus peripheral blood mononuclear cells
  publication-title: J Rheumatol
– volume: 54
  start-page: 336
  year: 2006
  ident: 2022010405183746300_b19
  article-title: Toll-like receptor 9 signaling protects against murine lupus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21553
– volume: 197
  start-page: 711
  year: 2003
  ident: 2022010405183746300_b27
  article-title: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
  publication-title: J Exp Med
  doi: 10.1084/jem.20021553
– volume: 21
  start-page: 231
  year: 2003
  ident: 2022010405183746300_b3
  article-title: BAFF and APRIL: a tutorial on B cell survival
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.21.120601.141152
– volume: 100
  start-page: 2610
  year: 2003
  ident: 2022010405183746300_b26
  article-title: Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0337679100
– volume: 25
  start-page: 417
  year: 2006
  ident: 2022010405183746300_b22
  article-title: Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus
  publication-title: Immunity
  doi: 10.1016/j.immuni.2006.07.013
– volume: 124
  start-page: 783
  year: 2006
  ident: 2022010405183746300_b10
  article-title: Pathogen reaction and innate immunity
  publication-title: Cell
  doi: 10.1016/j.cell.2006.02.015
– volume: 5
  start-page: 554
  year: 2006
  ident: 2022010405183746300_b6
  article-title: Type-I interferons and systemic lupus erythematosus
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2006.05.002
– volume: 40
  start-page: 1725
  year: 1997
  ident: 2022010405183746300_b15
  article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780400928
– volume: 4
  start-page: 825
  year: 2004
  ident: 2022010405183746300_b4
  article-title: A protective role for innate immunity in systemic lupus erythematosus
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1456
– volume: 307
  start-page: 590
  year: 2005
  ident: 2022010405183746300_b5
  article-title: Restoration of tolerance in lupus by targeted inhibitory receptor expression
  publication-title: Science
  doi: 10.1126/science.1105160
– volume: 36
  start-page: 511
  year: 2003
  ident: 2022010405183746300_b25
  article-title: Induction of clinical autoimmune disease by therapeutic interferon-alpha
  publication-title: Autoimmunity
  doi: 10.1080/08916930310001605873
– volume: 25
  start-page: 1271
  year: 1982
  ident: 2022010405183746300_b14
  article-title: The 1982 revised criteria for the classification of systemic lupus erythematosus
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780251101
– volume: 103
  start-page: 9970
  year: 2006
  ident: 2022010405183746300_b23
  article-title: A Tlr7 translocation accelerates systemic autoimmunity in murine lupus
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0603912103
– volume: 35
  start-page: 630
  year: 1992
  ident: 2022010405183746300_b16
  article-title: Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780350606
– volume: 54
  start-page: 3601
  year: 2006
  ident: 2022010405183746300_b11
  article-title: Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22197
– volume: 18
  start-page: 676
  year: 2006
  ident: 2022010405183746300_b7
  article-title: Systemic lupus erythematosus: all roads lead to type I interferons
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2006.09.014
– reference: 16947629 - Arthritis Rheum. 2006 Sep;54(9):2951-62
– reference: 16973388 - Immunity. 2006 Sep;25(3):429-40
– reference: 16027240 - J Exp Med. 2005 Jul 18;202(2):321-31
– reference: 12835292 - J Clin Pathol. 2003 Jul;56(7):481-90
– reference: 16497588 - Cell. 2006 Feb 24;124(4):783-801
– reference: 10955329 - J Rheumatol. 2000 Aug;27(8):1892-5
– reference: 16385525 - Arthritis Rheum. 2006 Jan;54(1):336-42
– reference: 17295441 - J Rheumatol. 2007 Mar;34(3):493-500
– reference: 7138600 - Arthritis Rheum. 1982 Nov;25(11):1271-7
– reference: 1599520 - Arthritis Rheum. 1992 Jun;35(6):630-40
– reference: 12604793 - Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2610-5
– reference: 16230478 - J Exp Med. 2005 Oct 17;202(8):1131-9
– reference: 17075805 - Arthritis Rheum. 2006 Nov;54(11):3601-11
– reference: 15681388 - Science. 2005 Jan 28;307(5709):590-3
– reference: 16777955 - Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9970-5
– reference: 12642603 - J Exp Med. 2003 Mar 17;197(6):711-23
– reference: 12427767 - Annu Rev Immunol. 2003;21:231-64
– reference: 16818796 - J Immunol. 2006 Jul 15;177(2):1349-54
– reference: 17011763 - Curr Opin Immunol. 2006 Dec;18(6):676-82
– reference: 17276080 - Semin Immunol. 2007 Feb;19(1):11-23
– reference: 17027892 - Autoimmun Rev. 2006 Oct;5(8):554-62
– reference: 1690258 - J Intern Med. 1990 Mar;227(3):207-10
– reference: 17307106 - Lancet. 2007 Feb 17;369(9561):587-96
– reference: 9324032 - Arthritis Rheum. 1997 Sep;40(9):1725
– reference: 17063184 - Nat Rev Immunol. 2006 Nov;6(11):823-35
– reference: 15459673 - Nat Rev Immunol. 2004 Oct;4(10):825-31
– reference: 14984028 - Autoimmunity. 2003 Dec;36(8):511-8
– reference: 16973389 - Immunity. 2006 Sep;25(3):417-28
SSID ssj0006662
Score 2.2982464
Snippet Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-α are...
Summary Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll‐like receptors (TLR‐7 and TLR‐9) and interferon (IFN)‐α are...
Recent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)-alpha are...
SummaryRecent studies in animal models for systemic lupus erythematosus (SLE) have shown that Toll-like receptors (TLR-7 and TLR-9) and interferon (IFN)- alpha...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
wiley
fao
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 482
SubjectTerms Adolescent
Adult
Aged
Analytical, structural and metabolic biochemistry
Antigens, Surface - biosynthesis
Antigens, Surface - genetics
Biological and medical sciences
Female
Fundamental and applied biological sciences. Psychology
GPI-Linked Proteins
Humans
Interferon-alpha - biosynthesis
Interferon-alpha - genetics
interferon-α
Leukocytes, Mononuclear - immunology
Lupus Erythematosus, Systemic - immunology
Male
Medical sciences
Membrane Proteins - biosynthesis
Membrane Proteins - genetics
Middle Aged
Molecular biophysics
mononuclear leukocytes
peripheral blood mononuclear cells
real-time reverse transcription-polymerase chain reaction
Reverse Transcriptase Polymerase Chain Reaction - methods
RNA, Messenger - genetics
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
systemic lupus erythematosus
Toll-like receptors
Toll-Like Receptors - biosynthesis
Toll-Like Receptors - genetics
Translational Studies
Up-Regulation - immunology
Title Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2249.2008.03646.x
https://www.ncbi.nlm.nih.gov/pubmed/18373699
https://www.proquest.com/docview/20439713
https://www.proquest.com/docview/47657661
https://www.proquest.com/docview/69190670
https://pubmed.ncbi.nlm.nih.gov/PMC2453201
Volume 152
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLZgCMQLl3FZuRQ_8JoqcWwnfuzGqoG0PYxV2ltkp_aoWpKqaaSNJ34B4jfySzgnTrsFBpoQb5VsJ83R8Tmf7c_fIeQt5BTFU6cDoYwIOOp9qogngbahynWkReTwRPfwSB6M-YdTcdryn_AujNeH2Gy44cxo4jVOcG2q7iRvGFqwfmgpkbHkcoB4EhsQHx1fKkkBSmfromqQIXmX1HPtgzqZ6rbTJfImdQWmc77mxXWg9Hdu5VXM2ySt0UMyW3-u56rMBvXKDPIvvyhB_h97PCIPWmxLh94ZH5Nbttgmd321y4ttcu-wPcd_Qr6NFz--fl_aMyweZifUnrd83IKWjp6Ab0LzfDqzFAKyXWBFIPr5-GhY0WlBUZu5EUOY04Z2T2EmlQXqMuslxYOIiuKlGdpKxlYU95qpl6ye5nReL-qK2uWF16stq7p6Ssaj_ZO9g6CtDBHkIk1lkLiEW8CKeZhrllphLCwj84lJmDWhYFqoWGg20bGx3MW41asixwxAE50DphLxM7IF_8zuEMoAYMnIxFaCj0JKN85MrFMsglFhaNMeSdZekOWtbDpW75hnV5ZPYPgMDd8W9UTDZ-c9Em1GLrx0yA3G7ICjZfoMInw2_sjwXDkESAkr5R7pd7xv80yGEkOAEnvkzdodM4gRaG9d2LKusub-cxL9pQdPJCw8ZfTnHmAehXe6euS5d_DLb0rjJJZKgaU6rr_pgArm3ZZi-qlRMmcc65LAW2Xj2Tc2U7a3_x5_vfjXgS_JfU_8we20V2Rrtazta0CXK9Mnd4a773ZH_SZ-_ATSwG85
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagiMeFR3l0ebQ-cM0qcWwnPlal1Ra6eyi7Um-WnXXKqiFZbTZSy4lfgPiN_BJmkuy2gYIqxC1S7DxG4_Hn8fj7CHkLc4ricWo8oazwOPJ9qoBHnnG-SkxgRJDiju5wJAcT_v5EnLRyQHgWpuGHWCfccGTU8RoHOCaku6O8LtGCBURbExlKLvsAKO-gwDcS6b87vuSSApzOVrJqMEfyblnPtU_qzFW3U1Ng5aQpwXhpo3pxHSz9vbryKuqtp62DRyRb_XBTrXLWr5a2n3z5hQvyP1nkMXnYwlu62_jjE3LL5ZvkbiN4ebFJ7g3brfyn5Ntk_uPr94U7Rf0wN6XuvC3JzWmR0jG4J9zOZmeOQkx2cxQFop-PR7slneUU6ZlrPoSM1pX3FAZTkSM1s1lQ3IsoKZ6boS1rbEkx3Uwb1upZQrNqXpXULS4aytqirMpnZHKwP94beK04hJeIOJZelEbcAVxM_MSw2AnrYCWZTG3EnPUFM0KFwrCpCa3jaYjZXhWkzAI6MQnAKhE-JxvwZW6LUAYYSwY2dBLcFGZ1m9qpSxULoJfvu7hHopUb6KRlTkcBj0xfWUGB4TUavtX1RMPr8x4J1j3nDXvIDfpsgadpcwpBXk8-Mtxa9gFVwmK5R7Y77rd-JkOWIQCKPbKz8kcNYQLtbXJXVKWuj0BHwV9a8EjC2lMGf24B5lF4rKtHXjQefvlPcRiFUimwVMf31w2QxLx7J599qsnMGUdpEnirrF37xmbSe_uHePXyXzvukPuD8fBIHx2OPrwiD5o6IMyuvSYby0Xl3gDYXNrtOoj8BA8-ceM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagiIoLj_JoeLQ-cM0qcRwnPlZtVy3QFSpdqbfITux2tUsSbTZSy4lfgPiN_BJmkuy2gYIqxC1S7DxGn2c-2-NvCHkLMUXy2Co3lDp0Oep9Sp9HrjKeTJWvQt_iju7RSByM-bvT8LTLf8KzMK0-xGrBDUdG469xgJeZ7Q_yJkML5g9dSmQguBgAn7zHhSexjMPe8ZWUFNB0tqyqBiGS97N6bnxSL1TdtarAxElVge1sW_TiJlb6e3LlddLbRK3hIzJd_m-brDId1As9SL_8IgX5fwzymDzsyC3dadH4hNwx-Qa535a7vNwg60fdRv5T8m1c_vj6fW7OsHqYyai56BJyc1pYegLghNuzydRQ8MimxJJA9PPxaKeik5yiOHOjhjCjTd49haFU5CjMrOYUdyIqiqdmaKcZW1FcbKatZvUkpbO6rCtq5petYG1R1dUzMh7un-weuF1pCDcN41i4kY24AbKYeqlisQm1gXlkmumIGe2FTIUyCBXLVKANtwGu9UrfMg3cRKVAqsLgOVmDLzObhDJgWMLXgREAUojp2urMWMl86OV5JnZItERBkna66Vi-Y5Zcmz-B4RM0fFfVEw2fXDjEX_UsW-2QW_TZBKAl6gxcfDL-xHBj2QNOCVNlh2z10Ld6JkONIaCJDtlewjEBJ4H2Vrkp6ippDkBH_l9a8EjAzFP4f24B5pF4qMshL1qAX_1THESBkBIs1YP-qgFKmPfv5JPzRsqccSxMAm8VDbJvbaZkd_8Qr17-a8dtsv5xb5h8OBy9f0UetElAuLT2mqwt5rV5A0xzobcaF_ITVXZwkg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Up-regulated+expression+of+Toll-like+receptors+mRNAs+in+peripheral+blood+mononuclear+cells+from+patients+with+systemic+lupus+erythematosus&rft.jtitle=Clinical+and+experimental+immunology&rft.au=Komatsuda%2C+A&rft.au=Wakui%2C+H&rft.au=Iwamoto%2C+K&rft.au=Ozawa%2C+M&rft.date=2008-06-01&rft.issn=0009-9104&rft.eissn=1365-2249&rft.volume=152&rft.issue=3&rft.spage=482&rft.epage=487&rft_id=info:doi/10.1111%2Fj.1365-2249.2008.03646.x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-9104&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-9104&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-9104&client=summon